CIBC Private Wealth Group’s SpringWorks Therapeutics SWTX Stock Holding History

CIBC Private Wealth Group’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43	Closed	-$2.02K	–	3301
2025 Q2	$2.02K	Sell	43 -38	-47%	-$1.69K	﹤0.01%	2638
2025 Q1	$2.89K	Buy	+81	New	+$3.73K	﹤0.01%	2603
2024 Q4	–	Sell	-74	Closed	-$2.37K	–	3179
2024 Q3	$2.37K	Hold	74	–	–	﹤0.01%	2775
2024 Q2	$2.82K	Hold	74	–	–	﹤0.01%	2685
2024 Q1	$3.52K	Buy	+74	New	+$3.42K	﹤0.01%	2605

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CIBC Private Wealth Group's SWTX Position: Q3 2025 in Review

CIBC Private Wealth Group sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 43 shares — an estimated $2.02K sold.

CIBC Private Wealth Group first reported a position in SWTX in Q1 2024 and held it in 5 quarters. The position peaked at $3.52K in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

CIBC Private Wealth Group reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
CIBC Private Wealth Group sold 43 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.02K.
CIBC Private Wealth Group first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 5 quarters.
CIBC Private Wealth Group's SpringWorks Therapeutics position peaked at $3.52K in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on CIBC Private Wealth Group's 13F filing for Q3 2025, filed 24 Nov 2025.